Global Hospital-acquired Disease Testing Market 2015-2019 - New Market Research Report

Fast Market Research announces the availability of Technavio's new report "Global Hospital Acquired Disease Testing Market 2015-2019" on their comprehensive research portal.

Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient.

Technavio's analysts forecast the global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.

Get More Details on this Report and a Full Table of Contents at Global Hospital-acquired Disease Testing Market 2015-2019

Commenting on the report, an analyst from Technavio’s team said: "The technological advance in the molecular diagnostic field is one of the key trends in the global hospital acquired disease testing market. The continuous innovation in increasing the performance and speed of molecular diagnostics is an integral part of the infectious diagnostic testing field."

According to the report, the rising prevalence of hospital acquired infections has a significant impact on both developed and developing countries and remains one of the major drivers of the growth of the market.

Further, the report states that lack of healthcare infrastructure, training, and awareness of how hospital acquired infections spread remain major hindrances to the growth of the market. Early diagnosis and regular monitoring of patients with these diseases is essential to identify, treat, and control their spread. This has generated substantial demand for hospital acquired disease testing products including instruments, testing kits, and reagents.

The key players in the Global Hospital Acquired Disease Testing Market are Abbott Laboratories Inc., Becton and Dickenson (BD), bioMerieux SA and Roche Diagnostics while other prominent vendors include Akers Biosciences, Alere, Beckman Coulter/Danaher, Cantel Medical, Cepheid, Diatherix Laboratories, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Gen-Probe, Humor Diagnostica, Life Technologies, Meridian Bioscience, Nordion and QIAGEN

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Sexually Transmitted Disease (STD) Testing Market 2014-2018
- Global Genetic Testing Market 2015-2019
- Global POC Lipid Testing Market 2015-2019
- Global Glycated Hemoglobin Testing Market 2015-2019
- Global Vitamin D Testing Market 2015-2019